Analgesics Market Trends 2023 | Segmentation, Outlook, Industry Report to 2033

 

According to FMI reports, the global analgesics market can soar at a rate CAGR of 4.2% from 2023-2033. The net worth of the market share of the analgesics industry is predicted to go from US$ 87.3 Mn in 2023 to over US$ 132.0 Mn by 2033.

People with acute, chronic diseases such as heart disease, cancer, diabetes, stroke, and arthritis, as well as infectious diseases like gastrointestinal, respiratory, and neurological ailments, are becoming increasingly common. Painkiller demand is on the rise as these diseases become more prevalent.

The geriatric population increase is a major factor in the increased demand for analgesics, major pharmaceutical companies manufacture and distribute analgesics, and consumer healthcare expenditure is rising.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1306

Clinical trials will continue to be conducted to evaluate the safety and efficacy of a wide range of therapeutic drugs, increasing the analgesics market. Furthermore, analgesics market trends are primarily driven by the growing number of elderly people, cardiovascular diseases, cancer, and arthritis.

This is driven by technological advancements in the pharmaceutical industry that allow advanced analgesic drugs to be manufactured, which will create remunerative opportunities for the analgesics market forecast period.

Key Takeaways from the Analgesics Market Study

·         The global analgesics market expanded at 6%CAGR over 2017-2022.

·         The U.S. dominates the North American analgesics market with a total share of 5%in 2022 and is projected to continue exhibiting high demand registering a CAGR of 3.5%.

·         Surgical pain holds a revenue share of 3%in 2023 and is projected to continue accounting for over half of sales in the market by 2033.

·         By drug type, the demand for opioids is projected to increase at a CAGR of8%during the forecast period.

·         Based on distribution channels, hospital pharmacies led the analgesics market with more than 1%market share with a CAGR of 5.4% in 2023.

·         The analgesics market is expected to increase at a notable CAGR of 4.2%.

Competitive Landscape for the Analgesics Market

In the development of non-opioid or non-addictive pain management formulations, key players are focusing on novel and innovative approaches. Manufacturers are expanding their markets, launching new products, and receiving approvals to further strengthen their position in the market.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1306

Pfizer Inc., Sun Pharmaceutical Industries, Inc., Sanofi SA, AbbVie Inc. (Allergan plc), Teva Pharmaceuticals, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Inc. [Johnson & Johnson], Endo Pharmaceuticals Inc., Purdue Pharmaceuticals L.P., Assertio Therapeutics, Inc., Mallinckrodt Pharmaceuticals, Bayer AG, GlaxoSmithKline plc., Bausch Health Companies Inc., Novartis AG, and others, the market is growing and establishing a strong global presence.

Analgesics Market Segmentation by Category

By Drug Class:

·         Opioids

·         NSAIDs

·         Local Anesthetics

·         Acetaminophen

By Indication:

·         Surgical Pain

·         Cancer Pain

·         Neuropathic Pain

By Route of Administration:

·         Oral

·         Parenteral

·         Transdermal

By Distribution Channel:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Drug Store

·         Clinics

·         Others

Full Report @ https://www.futuremarketinsights.com/reports/analgesics-market

Comments

Popular posts from this blog

Cardboard Flask Market Insights By Type, Industry, Application & End-User | FMI

Radiopharmaceuticals Market: Worldwide Industry Analysis and New Market Opportunities Explored to 2032

Voice Assistants Market Research Report 2022 – Global Forecast till 2032